Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) has issued an update.
Aurobindo Pharma has notified the stock exchanges that it will host an analyst and investor earnings call on 10 February 2026 at 8:30 a.m. IST to discuss its unaudited financial results for the third quarter and nine-month period ended 31 December 2025. The call, to be conducted via Zoom with prior registration, will be accompanied by an earnings presentation made available on the company’s website, underscoring its ongoing engagement with capital markets and commitment to transparent financial communication with stakeholders.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Limited is an India-based pharmaceutical company operating in the generic drugs industry, with a diversified portfolio across key therapeutic segments. The company serves global markets with formulation and active pharmaceutical ingredient (API) products, leveraging its manufacturing base and R&D capabilities to supply regulated and emerging markets worldwide.
Average Trading Volume: 38,247
Technical Sentiment Signal: Strong Buy
Current Market Cap: 704.1B INR
For a thorough assessment of AUROPHARMA stock, go to TipRanks’ Stock Analysis page.